【华纳药厂：子公司艾拉莫德原料药获上市申请批准】华纳药厂公告称，公司全资子公司湖南华纳大药厂手性药物有限公司收到国家药监局签发的艾拉莫德《化学原料药上市申请批准通知书》，该原料药登记号为Y20250000295，包装规格有5kg/桶、10kg/桶、25kg/桶，与制剂共同审评审批结果为A，已批准在国内制剂中使用。艾拉莫德是艾拉莫德片的原料药，后者主要用于治疗活动性类风湿关节炎。本次获批将丰富公司产品线，提升核心竞争力，该品种生产销售时间存在不确定性。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.